vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与ROCKY BRANDS, INC.（RCKY）财务数据对比。点击上方公司名可切换其他公司
ROCKY BRANDS, INC.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.9倍（$139.7M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 9.1%），ROCKY BRANDS, INC.自由现金流更多（$16.7M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 11.2%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
洛基品牌公司（原洛基鞋靴公司）1932年创立于俄亥俄州纳尔逊维尔，总部至今仍设于该地。公司主营户外、工装、西部风格及军用鞋靴的设计研发、生产与销售，同时也推出各类户外与工装服饰及周边配件。
PBYI vs RCKY — 直观对比
营收规模更大
RCKY
是对方的1.9倍
$75.5M
营收增速更快
PBYI
高出18.6%
9.1%
自由现金流更多
RCKY
多$2.3M
$14.4M
两年增速更快
PBYI
近两年复合增速
11.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $139.7M |
| 净利润 | — | $6.5M |
| 毛利率 | 69.3% | 41.3% |
| 营业利润率 | 22.7% | 6.9% |
| 净利率 | — | 4.7% |
| 营收同比 | 27.7% | 9.1% |
| 净利润同比 | — | 35.7% |
| 每股收益（稀释后） | $0.26 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIRCKY
| Q4 25 | $75.5M | $139.7M | ||
| Q3 25 | $54.5M | $122.5M | ||
| Q2 25 | $52.4M | $105.6M | ||
| Q1 25 | $46.0M | $114.1M | ||
| Q4 24 | $59.1M | $128.1M | ||
| Q3 24 | $80.5M | $114.6M | ||
| Q2 24 | $47.1M | $98.3M | ||
| Q1 24 | $43.8M | $112.9M |
净利润PBYIRCKY
| Q4 25 | — | $6.5M | ||
| Q3 25 | $8.8M | $7.2M | ||
| Q2 25 | $5.9M | $3.6M | ||
| Q1 25 | $3.0M | $4.9M | ||
| Q4 24 | — | $4.8M | ||
| Q3 24 | $20.3M | $5.3M | ||
| Q2 24 | $-4.5M | $-1.2M | ||
| Q1 24 | $-4.8M | $2.5M |
毛利率PBYIRCKY
| Q4 25 | 69.3% | 41.3% | ||
| Q3 25 | 77.7% | 40.2% | ||
| Q2 25 | 76.5% | 41.0% | ||
| Q1 25 | 77.1% | 41.2% | ||
| Q4 24 | 76.4% | 41.5% | ||
| Q3 24 | 63.9% | 38.1% | ||
| Q2 24 | 77.4% | 38.7% | ||
| Q1 24 | 75.5% | 39.1% |
营业利润率PBYIRCKY
| Q4 25 | 22.7% | 6.9% | ||
| Q3 25 | 17.6% | 9.6% | ||
| Q2 25 | 12.7% | 6.8% | ||
| Q1 25 | 8.7% | 7.6% | ||
| Q4 24 | 22.6% | 6.6% | ||
| Q3 24 | 27.4% | 8.8% | ||
| Q2 24 | -4.6% | 4.6% | ||
| Q1 24 | -5.3% | 7.1% |
净利率PBYIRCKY
| Q4 25 | — | 4.7% | ||
| Q3 25 | 16.2% | 5.9% | ||
| Q2 25 | 11.2% | 3.4% | ||
| Q1 25 | 6.5% | 4.3% | ||
| Q4 24 | — | 3.7% | ||
| Q3 24 | 25.2% | 4.6% | ||
| Q2 24 | -9.6% | -1.3% | ||
| Q1 24 | -11.0% | 2.3% |
每股收益（稀释后）PBYIRCKY
| Q4 25 | $0.26 | $0.86 | ||
| Q3 25 | $0.17 | $0.96 | ||
| Q2 25 | $0.12 | $0.48 | ||
| Q1 25 | $0.06 | $0.66 | ||
| Q4 24 | $0.40 | $0.65 | ||
| Q3 24 | $0.41 | $0.70 | ||
| Q2 24 | $-0.09 | $-0.17 | ||
| Q1 24 | $-0.10 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $2.9M |
| 总债务越低越好 | $22.7M | $122.6M |
| 股东权益账面价值 | $130.3M | $252.1M |
| 总资产 | $216.3M | $477.5M |
| 负债/权益比越低杠杆越低 | 0.17× | 0.49× |
8季度趋势，按日历期对齐
现金及短期投资PBYIRCKY
| Q4 25 | $97.5M | $2.9M | ||
| Q3 25 | $94.4M | $3.3M | ||
| Q2 25 | $96.0M | $2.8M | ||
| Q1 25 | $93.2M | $2.6M | ||
| Q4 24 | $101.0M | $3.7M | ||
| Q3 24 | $96.7M | $3.7M | ||
| Q2 24 | $96.8M | $4.1M | ||
| Q1 24 | $107.2M | $3.1M |
总债务PBYIRCKY
| Q4 25 | $22.7M | $122.6M | ||
| Q3 25 | $34.0M | $139.0M | ||
| Q2 25 | $45.3M | $132.5M | ||
| Q1 25 | $56.7M | $128.6M | ||
| Q4 24 | $68.0M | $128.7M | ||
| Q3 24 | $79.3M | $150.3M | ||
| Q2 24 | $90.7M | $152.4M | ||
| Q1 24 | $102.0M | $156.0M |
股东权益PBYIRCKY
| Q4 25 | $130.3M | $252.1M | ||
| Q3 25 | $115.3M | $246.1M | ||
| Q2 25 | $104.7M | $239.1M | ||
| Q1 25 | $97.1M | $236.2M | ||
| Q4 24 | $92.1M | $232.2M | ||
| Q3 24 | $71.1M | $228.3M | ||
| Q2 24 | $48.5M | $223.8M | ||
| Q1 24 | $51.0M | $225.3M |
总资产PBYIRCKY
| Q4 25 | $216.3M | $477.5M | ||
| Q3 25 | $202.9M | $494.0M | ||
| Q2 25 | $194.9M | $471.0M | ||
| Q1 25 | $196.2M | $468.2M | ||
| Q4 24 | $213.3M | $457.3M | ||
| Q3 24 | $220.7M | $475.0M | ||
| Q2 24 | $205.0M | $467.9M | ||
| Q1 24 | $214.1M | $466.5M |
负债/权益比PBYIRCKY
| Q4 25 | 0.17× | 0.49× | ||
| Q3 25 | 0.30× | 0.57× | ||
| Q2 25 | 0.43× | 0.55× | ||
| Q1 25 | 0.58× | 0.54× | ||
| Q4 24 | 0.74× | 0.55× | ||
| Q3 24 | 1.12× | 0.66× | ||
| Q2 24 | 1.87× | 0.68× | ||
| Q1 24 | 2.00× | 0.69× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $17.6M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $16.7M |
| 自由现金流率自由现金流/营收 | 19.1% | 12.0% |
| 资本支出强度资本支出/营收 | 0.0% | 0.6% |
| 现金转化率经营现金流/净利润 | — | 2.70× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $9.7M |
8季度趋势，按日历期对齐
经营现金流PBYIRCKY
| Q4 25 | $14.4M | $17.6M | ||
| Q3 25 | $9.7M | $-3.3M | ||
| Q2 25 | $14.1M | $812.0K | ||
| Q1 25 | $3.6M | $1.2M | ||
| Q4 24 | $15.6M | $24.4M | ||
| Q3 24 | $11.0M | $4.5M | ||
| Q2 24 | $1.0M | $6.5M | ||
| Q1 24 | $11.2M | $17.4M |
自由现金流PBYIRCKY
| Q4 25 | $14.4M | $16.7M | ||
| Q3 25 | $9.7M | $-5.2M | ||
| Q2 25 | $14.1M | $-2.4M | ||
| Q1 25 | $3.6M | $529.0K | ||
| Q4 24 | $15.6M | $22.9M | ||
| Q3 24 | $11.0M | $3.5M | ||
| Q2 24 | $1.0M | $4.6M | ||
| Q1 24 | — | $17.1M |
自由现金流率PBYIRCKY
| Q4 25 | 19.1% | 12.0% | ||
| Q3 25 | 17.7% | -4.2% | ||
| Q2 25 | 26.8% | -2.2% | ||
| Q1 25 | 7.7% | 0.5% | ||
| Q4 24 | 26.4% | 17.9% | ||
| Q3 24 | 13.7% | 3.0% | ||
| Q2 24 | 2.1% | 4.7% | ||
| Q1 24 | — | 15.2% |
资本支出强度PBYIRCKY
| Q4 25 | 0.0% | 0.6% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 0.0% | 3.0% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.0% | 1.2% | ||
| Q3 24 | 0.0% | 0.9% | ||
| Q2 24 | 0.0% | 1.9% | ||
| Q1 24 | 0.0% | 0.2% |
现金转化率PBYIRCKY
| Q4 25 | — | 2.70× | ||
| Q3 25 | 1.10× | -0.46× | ||
| Q2 25 | 2.41× | 0.23× | ||
| Q1 25 | 1.21× | 0.25× | ||
| Q4 24 | — | 5.08× | ||
| Q3 24 | 0.54× | 0.85× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 6.82× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
RCKY
| Wholesale | $79.6M | 57% |
| Retail1 | $57.0M | 41% |
| Contract Manufacturing | $3.2M | 2% |
